An Exploration of Anti-Inflammatory Therapy in Acute/Subacute Severe Cerebral Venous Thrombosis with Hereditary Protein C/S Deficiency: Case Series

References

• Stam J, Majoie CB, van Delden OM, van Lienden KP, Reekers JA. Endovascular thrombectomy and thrombolysis for severe cerebral sinus thrombosis: a prospective study. Stroke. 2008;39(5):1487–1490. doi:10.1161/STROKEAHA.107.502658
   PubMed Web of Science ®Google Scholar
• Kowoll CM, Kaminski J, Weiss V, et al. Severe cerebral venous and sinus thrombosis: clinical course, imaging correlates, and prognosis. Neurocrit Care. 2016;25(3):392–399. doi:10.1007/s12028-016-0256-8
   PubMed Web of Science ®Google Scholar
• Davoudi VKK, Saadatnia M, Saadatnia M. Risk factors for remote seizure development in patients with cerebral vein and dural sinus thrombosis. Seizure. 2014;23:135–139. doi:10.1016/j.seizure.2013.10.011
   PubMed Web of Science ®Google Scholar
• Appenzeller SZC, Annichino-Bizzachi JM, Annichino-Bizzachi JM, et al. Cerebral venous thrombosis: influence of risk factors and imaging findings on prognosis. Clin Neurol Neurosurg. 2005;107:371–378. doi:10.1016/j.clineuro.2004.10.004
   PubMed Web of Science ®Google Scholar
• Ferro JM, Bousser MG, Canhao P, et al. European stroke organization guideline for the diagnosis and treatment of cerebral venous thrombosis - Endorsed by the European Academy of Neurology. Eur Stroke J. 2017;2(3):195–221. doi:10.1177/2396987317719364
   PubMedGoogle Scholar
• Dentali F, Squizzato A, Gianni M, et al. Safety of thrombolysis in cerebral venous thrombosis. A systematic review of the literature. Thromb Haemost. 2010;104(5):1055–1062. doi:10.1160/TH10-05-0311
   PubMed Web of Science ®Google Scholar
• Coutinho JM, Zuurbier SM, Bousser MG, et al. Effect of endovascular treatment with medical management vs standard care on severe cerebral venous thrombosis: the TO-ACT randomized clinical trial. JAMA Neurol. 2020;77(8):966–973. doi:10.1001/jamaneurol.2020.1022
   PubMed Web of Science ®Google Scholar
• Karahan SZ, Gazioglu S, Dilaver I, Boz C. the role of thrombo-inflammatory biomarkers in the prognosis of cerebral venous sinus thrombosis. Curr Neurovasc Res. 2021;18(2):237–243. doi:10.2174/1567202618666210607151518
   PubMed Web of Science ®Google Scholar
• Walzik D, Joisten N, Zacher J, Zimmer P. Transferring clinically established immune inflammation markers into exercise physiology: focus on neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio and systemic immune-inflammation index. Eur J Appl Physiol. 2021;121(7):1803–1814. doi:10.1007/s00421-021-04668-7
   PubMed Web of Science ®Google Scholar
• Wang L, Duan J, Bian T, et al. Inflammation is correlated with severity and outcome of cerebral venous thrombosis. J Neuroinflammation. 2018;15(1):329. doi:10.1186/s12974-018-1369-0
   PubMedGoogle Scholar
• Duan J, Leng X, Han Z, et al. Identifying biomarkers associated with venous infarction in acute/subacute cerebral venous thrombosis. Aging Dis. 2021;12(1):93–101. doi:10.14336/AD.2020.0405
   PubMed Web of Science ®Google Scholar
• Suleiman L, Negrier C, Boukerche H. Protein S: a multifunctional anticoagulant vitamin K-dependent protein at the crossroads of coagulation, inflammation, angiogenesis, and cancer. Crit Rev Oncol Hematol. 2013;88(3):637–654. doi:10.1016/j.critrevonc.2013.07.004
   PubMed Web of Science ®Google Scholar
• Dinarvand P, Moser KA. Protein C Deficiency. Arch Pathol Lab Med. 2019;143(10):1281–1285. doi:10.5858/arpa.2017-0403-RS
   PubMed Web of Science ®Google Scholar
• Aksu K, Donmez A, Keser G. Inflammation-induced thrombosis: mechanisms, disease associations and management. Curr Pharm Des. 2012;18(11):1478–1493. doi:10.2174/138161212799504731
   PubMed Web of Science ®Google Scholar
• Margetic S. Inflammation and haemostasis. Biochem Med. 2012;22(1):49–62. doi:10.11613/BM.2012.006
   PubMed Web of Science ®Google Scholar
• Hu S, Lee H, Zhao H, Ding Y, Duan J. Inflammation and severe cerebral venous thrombosis. Front Neurol. 2022;13:873802. doi:10.3389/fneur.2022.873802
   PubMed Web of Science ®Google Scholar
• Singhal AB, Topcuoglu MA. Glucocorticoid-associated worsening in reversible cerebral vasoconstriction syndrome. Neurology. 2017;88(3):228–236. doi:10.1212/WNL.0000000000003510
   PubMed Web of Science ®Google Scholar
• Canhao P, Cortesao A, Cabral M, et al. Are steroids useful to treat cerebral venous thrombosis? Stroke. 2008;39(1):105–110. doi:10.1161/STROKEAHA.107.484089
   PubMed Web of Science ®Google Scholar
• Saposnik G, Barinagarrementeria F, Brown RD, et al. Diagnosis and management of cerebral venous thrombosis: a statement for healthcare professionals from the American heart association/American Stroke Association. Stroke. 2011;42(4):1158–1192. doi:10.1161/STR.0b013e31820a8364
   PubMed Web of Science ®Google Scholar
• Fan Y, Yu J, Chen H, et al. Chinese stroke association guidelines for clinical management of cerebrovascular disorders: executive summary and 2019 update of clinical management of cerebral venous sinus thrombosis. Stroke Vasc Neurol. 2020;5(2):152–158. doi:10.1136/svn-2020-000358
   PubMedGoogle Scholar
• Yang Q, Duan J, Fan Z, et al. Early detection and quantification of cerebral venous thrombosis by magnetic resonance black-blood thrombus imaging. Stroke. 2016;47(2):404–409. doi:10.1161/STROKEAHA.115.011369
   PubMed Web of Science ®Google Scholar
• Connor SE, Jarosz JM. Magnetic resonance imaging of cerebral venous sinus thrombosis. Clin Radiol. 2002;57(6):449–461. doi:10.1053/crad.2001.0880
   PubMed Web of Science ®Google Scholar
• Wypasek E, Undas A. Protein C and protein S deficiency - practical diagnostic issues. Adv Clin Exp Med. 2013;22(4):459–467.
   PubMed Web of Science ®Google Scholar
• Qureshi AI, Classification A. Scheme for assessing recanalization and collateral formation following cerebral venous thrombosis. J Vasc Interv Neurol. 2010;3(1):1–2.
   PubMedGoogle Scholar
• Stanbury RM, Graham EM. Systemic corticosteroid therapy--side effects and their management. Br J Ophthalmol. 1998;82(6):704–708. doi:10.1136/bjo.82.6.704
   PubMed Web of Science ®Google Scholar
• Fang F, Xu Z, Suo Y, et al. Gene panel for Mendelian strokes. Stroke Vasc Neurol. 2020;5(4):416–421. doi:10.1136/svn-2020-000352
   PubMedGoogle Scholar
• Saito K, Ishii K, Furuta K, Kobayashi M, Wada Y, Morishita E. Recurrent cerebral venous thrombosis treated with direct oral anticoagulants in a Japanese man with hereditary protein C deficiency. J Stroke Cerebrovasc Dis. 2021;30(1):105320. doi:10.1016/j.jstrokecerebrovasdis.2020.105320
   PubMed Web of Science ®Google Scholar
• Wang T, Zhao XJ, Zhu HD, Lu M, Wen B, Ma L. Clinical characteristics, genes identification and follow-up study of a patient with central venous thrombosis from a protein S deficiency pedigree. Eur Rev Med Pharmacol Sci. 2021;25(1):353–361. doi:10.26355/eurrev_202101_24402
   PubMed Web of Science ®Google Scholar
• Xu Z, Li X, Feng D, et al. Endovascular therapy versus anticoagulation for treatment of cerebral venous sinus thrombosis: a meta-analysis. Neurologist. 2021;27(2):69–73. doi:10.1097/NRL.0000000000000369
   PubMed Web of Science ®Google Scholar
• Zhang B, Lang Y, Zhang W, Cui L, Deng F. Characteristics and management of autoimmune disease-associated cerebral venous sinus thrombosis. Front Immunol. 2021;12:671101. doi:10.3389/fimmu.2021.671101
   PubMed Web of Science ®Google Scholar
• Ferro JM, Bousser MG, Canhao P, et al. European stroke organization guideline for the diagnosis and treatment of cerebral venous thrombosis - endorsed by the European Academy of Neurology. Eur J Neurol. 2017;24(10):1203–1213. doi:10.1111/ene.13381
   PubMed Web of Science ®Google Scholar
• Vidale S, Consoli A, Arnaboldi M, Consoli D. Postischemic inflammation in acute stroke. J Clin Neurol. 2017;13(1):1–9. doi:10.3988/jcn.2017.13.1.1
   PubMed Web of Science ®Google Scholar
• Piazza G. Cerebral venous thrombosis. Circulation. 2012;125(13):1704–1709. doi:10.1161/CIRCULATIONAHA.111.067835
   PubMed Web of Science ®Google Scholar
• de la Vega Muns G, Quencer R, Ezuddin NS, Saigal G. Utility of Hounsfield unit and hematocrit values in the diagnosis of acute venous sinus thrombosis in unenhanced brain CTs in the pediatric population. Pediatr Radiol. 2019;49(2):234–239. doi:10.1007/s00247-018-4273-y
   PubMed Web of Science ®Google Scholar
• Tekesin A, Tunc A. Inflammatory markers are beneficial in the early stages of cerebral venous thrombosis. Arq Neuropsiquiatr. 2019;77(2):101–105. doi:10.1590/0004-282x20190001
   PubMed Web of Science ®Google Scholar
• Rashad S, Niizuma K, Sato-Maeda M, et al. Early BBB breakdown and subacute inflammasome activation and pyroptosis as a result of cerebral venous thrombosis. Brain Res. 2018;1699:54–68. doi:10.1016/j.brainres.2018.06.029
   PubMed Web of Science ®Google Scholar
• Petrovic-Djergovic D, Goonewardena SN, Pinsky DJ. Inflammatory Disequilibrium in Stroke. Circ Res. 2016;119(1):142–158. doi:10.1161/CIRCRESAHA.116.308022
   PubMed Web of Science ®Google Scholar
• Aguiar de Sousa D, Pereira-Santos MC, Serra-Caetano A, et al. Blood biomarkers associated with inflammation predict poor prognosis in cerebral venous thrombosis:: a multicenter prospective observational study. Eur J Neurol. 2021;28(1):202–208. doi:10.1111/ene.14526
   PubMed Web of Science ®Google Scholar
• McDonnell CJ, Soule EE, Walsh PT, O’Donnell JS, Preston RJS. The immunoregulatory activities of activated protein C in inflammatory disease. Semin Thromb Hemost. 2018;44(2):167–175. doi:10.1055/s-0037-1608910
   PubMed Web of Science ®Google Scholar
• Griffin JH, Zlokovic BV, Mosnier LO. Protein C anticoagulant and cytoprotective pathways. Int J Hematol. 2012;95(4):333–345. doi:10.1007/s12185-012-1059-0
   PubMed Web of Science ®Google Scholar
• Dinarvand P, Hassanian SM, Weiler H, Rezaie AR. Intraperitoneal administration of activated protein C prevents postsurgical adhesion band formation. Blood. 2015;125(8):1339–1348. doi:10.1182/blood-2014-10-609339
   PubMed Web of Science ®Google Scholar
• Galley HF, El Sakka NE, Webster NR, Lowes DA, Cuthbertson BH. Activated protein C inhibits chemotaxis and interleukin-6 release by human neutrophils without affecting other neutrophil functions. Br J Anaesth. 2008;100(6):815–819. doi:10.1093/bja/aen079
   PubMed Web of Science ®Google Scholar
• O’Brien LM, Mastri M, Fay PJ. Regulation of factor VIIIa by human activated protein C and protein S: inactivation of cofactor in the intrinsic factor Xase. Blood. 2000;95(5):1714–1720. doi:10.1182/blood.V95.5.1714.005k40_1714_1720
   PubMed Web of Science ®Google Scholar
• van der Meer JH, van der Poll T, van ‘t Veer C. TAM receptors, Gas6, and protein S: roles in inflammation and hemostasis. Blood. 2014;123(16):2460–2469. doi:10.1182/blood-2013-09-528752
   PubMed Web of Science ®Google Scholar
• Rothlin CV, Ghosh S, Zuniga EI, Oldstone MB, Lemke G. TAM receptors are pleiotropic inhibitors of the innate immune response. Cell. 2007;131(6):1124–1136. doi:10.1016/j.cell.2007.10.034
   PubMed Web of Science ®Google Scholar
• De Caterina R, D’Ugo E, Libby P. Inflammation and thrombosis - testing the hypothesis with anti-inflammatory drug trials. Thromb Haemost. 2016;116(6):1012–1021. doi:10.1160/TH16-03-0246
   PubMed Web of Science ®Google Scholar
• Vazquez-Garza E, Jerjes-Sanchez C, Navarrete A, Joya-Harrison J, Rodriguez D. Venous thromboembolism: thrombosis, inflammation, and immunothrombosis for clinicians. J Thromb Thrombolysis. 2017;44(3):377–385. doi:10.1007/s11239-017-1528-7
   PubMed Web of Science ®Google Scholar
• van der Poll T, de Jonge E, Levi M. Regulatory role of cytokines in disseminated intravascular coagulation. Semin Thromb Hemost. 2001;27(6):639–651. doi:10.1055/s-2001-18868
   PubMed Web of Science ®Google Scholar
• Peerschke EI, Yin W, Ghebrehiwet B. Platelet mediated complement activation. Adv Exp Med Biol. 2008;632:81–91. doi:10.1007/978-0-387-78952-1_7
   PubMed Web of Science ®Google Scholar
• Barnes PJ. Anti-inflammatory actions of glucocorticoids: molecular mechanisms. Clin Sci (Lond). 1998;94(6):557–572. doi:10.1042/cs0940557
   PubMed Web of Science ®Google Scholar
• Slivka AP, Murphy EJ. High-dose methylprednisolone treatment in experimental focal cerebral ischemia. Exp Neurol. 2001;167(1):166–172. doi:10.1006/exnr.2000.7532
   PubMed Web of Science ®Google Scholar